Image Guided Interventions Laboratory (GR-949), Faculty of Medicine, University of Geneva, Geneva, Switzerland.
University of Avignon, CBSA-IBMM, (UMR5247), Avignon, France.
Int J Hyperthermia. 2020;37(1):1116-1130. doi: 10.1080/02656736.2020.1817575.
High intensity focused ultrasound (HIFU) is clinically accepted for the treatment of solid tumors but remains challenging in highly perfused tissue due to the heat sink effect. Endovascular liquid-core sonosensitizers have been previously suggested to enhance the thermal energy deposition at the focal area and to lower the near-/far-field heating. We are investigating the therapeutic potential of PFOB-FTAC micro-droplets in a perfused tissue-mimicking model and postmortem excised organs.
A custom-made perfused tissue-mimicking model, freshly excised pig kidneys ( = 3) and liver ( = 1) were perfused and subjected to focused ultrasound generated by an MR-compatible HIFU transducer. PFOB-FTAC sonosensitizers were injected in the perfusion fluid up to 0.235% v/v ratio. Targeting and on-line PRFS thermometry were performed on a 3 T MR scanner. Assessment of the fluid perfusion was performed with pulsed color Doppler and with dynamic contrast-enhanced (DCE)-MRI in excised organs.
Our model of perfused tissue demonstrated re-usability. Sonosensitizer concentration and perfusion rate were tunable . Differential heating under equivalent HIFU sonications demonstrated a dramatic improvement in the thermal deposition due to the sonosensitizers activity. Typically, the energy deposition was multiplied by a factor between 2.5 and 3 in perfused organs after the administration of micro-droplets, while DCE-MRI indicated an effective perfusion.
The current PFOB-FTAC micro-droplet sonosensitizers provided a large and sustained enhancement of the HIFU thermal deposition at the focal area, suggesting solutions for less technological constraints, lower risk for the near-/far- field heating. We also report a suitable experimental model for other MRgHIFU studies.
高强度聚焦超声(HIFU)已在临床中被接受用于治疗实体肿瘤,但由于热沉效应,在高灌注组织中仍具有挑战性。先前已经提出了血管内液芯声敏剂,以增强在焦点区域的热能沉积,并降低近场/远场加热。我们正在研究 PFOB-FTAC 微液滴在灌注组织模拟模型和离体器官中的治疗潜力。
使用定制的灌注组织模拟模型,新鲜离体猪肾(n=3)和肝(n=1)进行灌注,并接受由磁共振兼容 HIFU 换能器产生的聚焦超声。PFOB-FTAC 声敏剂以 0.235%v/v 的比例注入灌注液中。在 3TMR 扫描仪上进行靶向和在线 PRFS 测温。在离体器官中使用脉冲彩色多普勒和动态对比增强(DCE)-MRI 评估灌注。
我们的灌注组织模型显示可重复使用。声敏剂浓度和灌注率可调。在等效 HIFU 超声下的差异加热表明,由于声敏剂的活性,热沉积得到了显著改善。通常,在微液滴给药后,灌注器官中的能量沉积增加了 2.5 到 3 倍,而 DCE-MRI 则表明了有效的灌注。
目前的 PFOB-FTAC 微液滴声敏剂在焦点区域提供了 HIFU 热沉积的大幅且持续增强,这为解决技术限制、降低近场/远场加热风险提供了可能。我们还报告了一种适合其他 MRgHIFU 研究的实验模型。